🇮🇹 Italy Country × Condition
multiple sclerosis Clinical Trials in Italy
Active clinical trials for multiple sclerosis with research sites in Italy. All data sourced live from ClinicalTrials.gov — updated daily.
Active Trials: 5 // Recruiting: 5 // Updated: Daily
Total Trials
5
Recruiting Now
5
Country
🇮🇹 Italy
Active Trials in Italy (5)
NCT06820125
Recruiting
Isolated Versus Combined Cognitive and Motor High-tech Rehabilitation
Enrollment
48 pts
Country
🇮🇹 Italy
Universita di Verona
View Trial → NCT05748015
Recruiting
Definition of Autonomic Nervous System Involvement in Patients With Multiple Sclerosis
Enrollment
60 pts
Country
🇮🇹 Italy
Istituti Clinici Scientifici Mauger...
View Trial → NCT07058896
Recruiting
Unravelling The Optimisation And Consolidation Of Motor Skills In People With Multiple Sclerosis With Severe Gait Impairment: A Feasibility Study
Enrollment
18 pts
Country
🇮🇹 Italy
University Hospital of Ferrara
View Trial → NCT05713890
Recruiting
Home-based Action Observation Treatment With Virtual-reality for Arm Rehabilitation in People With Multiple Sclerosis
Enrollment
60 pts
Country
🇮🇹 Italy
IRCCS San Raffaele
View Trial → NCT07066137
Recruiting
Motor Learning in Health and Movement Disorders: Role of Physical Activity and Advanced Devices
Enrollment
150 pts
Country
🇮🇹 Italy
IRCCS Centro Neurolesi Bonino Pulej...
View Trial → Frequently Asked Questions
How many multiple sclerosis clinical trials are active in Italy?
There are currently 5 active clinical trials for multiple sclerosis with sites in Italy, of which 5 are actively recruiting patients.
How can I join a multiple sclerosis clinical trial in Italy?
To join a multiple sclerosis clinical trial in Italy, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in Italy directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are multiple sclerosis trials in Italy?
Active multiple sclerosis trials in Italy span multiple phases. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology